The FDA is looking for advice for continuing RSV vaccine development in infants and toddlers while avoiding the risk of vaccine-associated enhanced respiratory disease. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
